Antibody design could fight COVID-19 before vaccines arrive
While the world is paralyzed by the high-risk race to develop a COVID-19 vaccine, equally crucial competition is heating up to produce targeted antibodies that could provide an instant immune boost against the virus.Clinical trials of these monoclonal antibodies, which could prevent and treat the disease, are already underway and could produce signs of efficacy in the coming months, perhaps before vaccine trials."If you were to deposit your money, I'd bet you get the answer with the monoclonal before getting the answer with a vaccine," says Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID).
